– Transplant renewed for Season 3
– Season 3 gets US-release on NBC
– No official release date announced yet
The medical drama series, Transplant, has been officially renewed for its third season and will also air in the United States on NBC. While an exact release date has not been disclosed, it has been confirmed that production for the third season is already underway in Montreal, Quebec, Canada.
Transplant centers around a Syrian refugee, gifted surgeon Dr. Bashir “Bash” Hamed, who flees his war-torn country and relocates to Canada with his younger sister. He does his best to rebuild his career in a new environment while dealing with new challenges and prejudices. The series has achieved critical success and a strong following since its debut in 2020. It was also one of the few series that completed its first season despite the onset of the COVID-19 pandemic.
NBC had already picked up the drama for its first two seasons through a deal with Canadian broadcaster CTV. The show’s Canadian fan base has offered strong support, with Season 2 becoming the most-watched Canadian program with an average of 1.3 million viewers, according to Numeris.
Brad Wright, an executive producer on Transplant, shared his excitement for the renewal on Twitter: “So happy to share that our little show has been picked up for Season 3! Thanks to CTV and NBC for sticking with us. Thanks to the incredible team that works so hard to make #Transplant such a special show. Such great news, very proud of you all!”
While fans eagerly await the third season, they can take comfort in the knowledge that their beloved series will continue to inspire and entertain with its gripping stories and captivating performances.